•  
  •  
  •  
  •  

2025-08-31 19:03:03

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Titan unveils 8 new brand outlets across Delhi NCR, strengthening their retail footprint with 1000+ stores in FY26
  • Zigly Unveils New Experience Centre at Phoenix Marketcity, Strengthens Mumbai Presence
  • XTGlobal Infotech Ltd and ICICI Bank Ltd enter into loan agreement
  • NCC Limited receives orders worth Rs. 788.34 crore
  • Thomas Cook India & SOTC Travel ink long-term strategic MOU with Queensland Tourism

Keywords Selected:  Biotech

IPO News

  • Concord Biotech Limited's IPO to open on Friday, 4th August, 2023, sets price band at ₹705 to ₹741 per Equity Share
  • Windlas Biotech Ltd posts consolidated PAT of Rs. 11.44 crores in Q4FY23
  • Ahmedabad-based Concord Biotech gets SEBI nod for IPO
  • Rare Enterprises and Quadria Capital-backed Concord Biotech files DRHP for IPO

Stock Report

  • Concord Biotech Limited completes EUGMP inspection at its API facility
  • Vivo Bio Tech Ltd secures landmark Pre-Clinical Testing Contract Valued at ₹10.75 Crores
  • Fermenta announces Granting of CEP by EDQM for VITADEE™ 100 SD, Enabling Accelerated Global Growth
  • Concord Biotech Ltd successfully completes Russian GMP insepction at its API facility
  • Shilpa Medicare Backs US Biotech Alveolus Bio to Accelerate Next‐Gen Lung Disease Therapies
  • Rossari Biotech Ltd posts consolidated PAT of Rs. 33.59 crores in Q1 FY26
  • Concord Biotech Ltd announces successful completion EU GMP inspection at its API facility
  • Fermenta Signs Strategic MoU with NIFTEM-T to Strengthen India's Food Fortification Landscape
  • Indo Us Bio Tech Ltd signs MOU with ICAR-IARI
  • Concord Biotech Limited receives EIR from USFDA for API facility at Dholka
  • USFDA Inspection at Concord Biotech Ltd's API facility at Dholka
  • Fermenta enters its 75th Year, Celebrating a Legacy Built on Trust
  • Rossari Biotech Limited recommends final dividend of Rs. 0.50
  • Rossari Biotech Ltd Q4FY25 consolidated profit up at Rs. 34.44 crores
  • Rossari Biotech Limited subsidiaries announce capacity expansion
  • Coastal Corporation Ltd updates on Policy Development - Ethanol blending target raised to 30% by 2030
  • Concord Biotech Limited receives final approval from USFDA for Teriflunomide Tablets
  • Medicamen Biotech Ltd signs distribution agreement with XGX Pharma, Denmark for 3 products
  • Medicamen Biotech Limited signs CDMO contract with XGX Pharma
  • Coastal Biotech Pvt Ltd starts trial runs at its Ethanol Plant
  • Concord Biotech Limited commences production of injectable at new facility
  • Medicamen Biotech enters into understanding with South African business conglomerate
  • Fermenta's Plant-based Vitamin D3 is 'Innovation of the Year'
  • Medicamen Biotech Ltd recognized by EPSS

Latest Post

  • Titan unveils 8 new brand outlets across Delhi NCR, strengthening their retail footprint with 1000+ stores in FY26
  • Zigly Unveils New Experience Centre at Phoenix Marketcity, Strengthens Mumbai Presence
  • XTGlobal Infotech Ltd and ICICI Bank Ltd enter into loan agreement
  • NCC Limited receives orders worth Rs. 788.34 crore
  • Thomas Cook India & SOTC Travel ink long-term strategic MOU with Queensland Tourism


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024